| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.8M | -54.7% |
| R&D Expense | $42.6M | +2.2% |
| SG&A Expense | $44.9M | +77.0% |
| Operating Income | -$62.7M | -415.9% |
| Interest Expense | $2.2M | — |
| Pre-tax Income | -$62.1M | -350.9% |
| Income Tax | -$4K | -107.3% |
| Net Income | -$62.1M | -349.1% |
| EPS (Basic) | -$2.52 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.7M | -58.2% |
| Short-term Investments | $145.4M | — |
| Current Assets | $225.4M | +28.1% |
| Total Assets | $227.9M | +27.4% |
| Current Liabilities | $15.4M | +34.4% |
| Long-term Debt | $19.4M | — |
| Total Liabilities | $35.0M | +187.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -1408.2% |
| Capital Expenditures | $506K | -13.7% |
| Investing Cash Flow | -$144.6M | — |
| Financing Cash Flow | $94.0M | — |
| Free Cash Flow | -$49.5M | -1666.6% |
| -276.1% |
| EPS (Diluted) | -$2.52 | -276.1% |
| Stockholders' Equity |
| $192.9M |
| +15.7% |